Entrada Therapeutics, Inc. logo TRDA - Entrada Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $17.00 DETAILS
HIGH: $21.00
LOW: $10.00
MEDIAN: $20.00
CONSENSUS: $17.00
UPSIDE: 159.15%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0.9 1.3 1.6 1.9 20.6 37.4 19.6 94.7 59.1 41.8 43.7 18.2 25.3 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.8 0.9 38.4 0 0 0 0 0 0 0 22.2 26.3 23.1 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0.1 0.4 (36.7) 1.9 20.6 37.4 19.6 94.7 59.1 41.8 21.5 (8.1) 2.2 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 33.1 34.0 38.4 37.9 32.1 33.4 31.3 32.0 28.6 28.3 22.2 26.3 23.1 15.7 19.0 16.2 15.7 12.4 10.5 6.8 6.2 6.7 5.7 4.4 4.4
SG&A Expenses 10.1 9.6 10.3 10.9 10.3 9.9 10.0 9.2 9.4 8.7 7.5 8.2 7.9 9.9 7.0 7.3 6.4 6.1 3.9 3.1 2.2 2.0 1.3 1.1 1.1
Other Expenses (0.8) (0.9) (38.4) 0 0 0 0 0 0 0 (22.2) (26.3) (23.1) 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 42.4 42.6 10.3 48.8 42.3 43.3 41.2 41.3 38.0 36.9 7.5 8.2 7.9 25.6 25.9 23.6 22.2 18.5 14.4 9.9 8.4 8.7 7.0 5.5 5.5
Operating Income
Operating Income (42.3) (42.2) (47.1) (46.8) (21.8) (5.9) (21.7) 53.4 21.1 4.9 14.0 (16.3) (5.8) (25.6) (25.9) (23.6) (22.2) (18.5) (14.4) (9.9) (8.4) (8.7) (7.0) (5.5) (5.5)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0.0 0.0 0 0
Interest Income 0 0 0 3.9 4.4 5.1 5.8 4.4 4.2 4.3 4.1 4.2 2.7 0 0.8 0.4 0.5 0.0 0 0.0 0.0 0 0 0 0
Profitability
EBITDA (41.5) (41.9) (42.2) (45.8) (20.8) (4.9) (20.7) 54.3 22.0 5.6 14.8 (15.6) (5.2) (25.1) (25.4) (23.1) (21.8) (18.1) (14.1) (9.7) (8.2) (8.6) (6.9) (5.5) (5.5)
EBIT (42.3) (39.1) (43.5) (46.8) (21.8) (5.9) (21.7) 53.4 21.1 4.9 14.0 (16.3) (5.8) (25.6) (25.9) (23.6) (22.2) (18.5) (14.4) (9.9) (8.4) (8.7) (7.0) (5.5) (5.5)
Income Before Tax (39.7) (39.1) (43.5) (42.9) (17.3) (0.7) (15.9) 57.8 25.3 9.2 52.9 (12.1) (3.1) (24.6) (25.1) (23.2) (21.7) (18.4) (14.4) (9.9) (8.4) (8.7) (7.0) (5.4) (5.4)
Income Tax Expense 0.0 0.1 0.7 0.2 0 (1.9) (1.9) 2.8 1.8 18.7 17.4 13.8 3.6 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (39.7) (39.2) (44.1) (43.1) (17.3) 1.1 (14.0) 55.0 23.5 (9.5) 35.5 (25.9) (6.7) (24.6) (25.1) (23.2) (21.7) (18.4) (14.4) (9.9) (8.4) (8.7) (7.0) (5.4) (5.4)
Per Share Data
EPS (Basic) -0.95 -0.95 -1.06 -1.04 -0.42 0.03 -0.35 1.61 0.70 -0.29 1.07 -0.78 -0.21 -0.71 -0.75 -0.72 -0.66 -0.89 -0.51 -0.48 -0.41 -0.42 -0.34 -5.18 -5.18
EPS (Diluted) -0.95 -0.95 -1.06 -1.04 -0.42 0.03 -0.35 1.55 0.68 -0.29 1.02 -0.78 -0.21 -0.71 -0.75 -0.72 -0.66 -0.89 -0.51 -0.48 -0.41 -0.42 -0.34 -5.18 -5.18
Shares Outstanding 41.8 41.4 41.5 41.3 41.1 40.8 40.6 34.2 33.5 33.4 33.3 33.2 32.4 31.4 31.3 31.3 31.2 20.8 28.3 20.5 20.5 20.5 20.5 1.0 1.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q1
Current Assets
Cash & Cash Equivalents 76.4 90.4 93.3 72.5 67.8 101.2 78.0 185.3 68.4 67.6 51.9 79.7 227.6 45.2 53.3 90.9 84.6 291.1 122.2 136.9 39.0 39.0 16.8
Short-Term Investments 178.4 205.3 233.6 281.5 314.7 318.8 371.3 284.5 259.0 284.4 301.7 297.0 184.0 143.6 162.3 153.4 179.3 0 0 0 0 0 0
Net Receivables 0 0 3.2 1.2 2.0 3.7 2.6 7.7 77.5 5.9 5.0 3.7 6.3 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 12.0 10.6 8.2 14.0 18.6 16.4 13.4 12.1 9.2 11.9 24.4 9.7 16.2 21.2 0 0 0 0 0 0 0 0 0
Total Current Assets 266.9 306.3 338.3 369.1 403.2 440.0 465.3 489.5 414.2 369.8 383.0 390.2 434.1 209.9 234.7 253.9 272.7 298.7 123.5 137.6 39.0 39.9 16.8
Non-Current Assets
Property, Plant & Equipment 65.3 67.8 70.5 75.5 79.1 82.0 84.6 87.7 90.0 92.7 95.1 99.3 23.6 33.0 34.8 37.2 38.6 6.3 5.9 5.1 0 3.0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3.4 3.4 0.2 4.1 4.2 4.2 4.7 4.7 6.7 6.7 6.9 4.5 17.8 9.2 4.9 4.8 5.4 0.9 3.0 0.8 (39.0) 0.5 (16.8)
Total Non-Current Assets 68.6 71.1 74.6 79.6 83.3 86.3 89.3 92.4 96.7 99.4 102.0 103.8 41.4 42.2 39.7 42.0 44.0 7.1 8.9 5.9 (39.0) 3.6 (16.8)
Total Assets 335.5 377.4 412.9 448.8 486.5 526.3 554.6 582.0 510.8 469.2 485.0 494.0 475.6 252.1 274.5 295.9 316.7 305.8 132.4 143.5 0 43.5 0
Current Liabilities
Account Payables 2.9 2.3 3.2 1.9 2.2 4.3 1.3 1.6 2.5 3.3 0.8 2.4 6.5 6.0 1.3 4.6 2.9 0.7 2.3 1.9 0 1.6 0
Short-Term Debt 4.3 4.1 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0.3 0.3 0.4 0.7 1.4 13.7 45.9 60.5 148.5 132.3 148.4 101.6 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 11.7 17.7 8.6 4.7 4.2 8.4 7.6 4.5 3.8 7.7 6.1 3.8 125.6 5.5 4.3 2.8 2.2 0.5 3.1 0.4 0 0.1 0
Total Current Liabilities 19.2 24.5 24.0 19.8 18.4 39.5 70.6 85.8 173.9 158.8 165.4 125.9 147.6 22.0 21.6 18.1 15.4 6.7 7.2 4.5 0 3.4 0
Non-Current Liabilities
Long-Term Debt 45.5 46.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 89.2 0 0 0 0 0.4 197.8 198.0 (40.2) 81.7 (16.3)
Total Non-Current Liabilities 45.5 46.8 48.2 49.5 50.8 58.2 61.5 66.2 67.5 68.0 72.9 161.1 98.4 17.5 19.7 21.8 23.9 0.4 197.8 198.0 (40.2) 81.7 (16.3)
Total Liabilities 64.7 71.2 72.2 69.3 69.2 97.6 132.1 152.0 241.5 226.8 238.4 287.1 246.0 39.5 41.2 39.9 39.3 7.1 205.0 202.5 (40.2) 85.0 (16.3)
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0
Retained Earnings (312.8) (273.1) (233.9) (189.8) (146.7) (129.3) (130.5) (116.4) (171.5) (195.0) (185.4) (220.9) (195.0) (188.3) (163.7) (138.5) (115.3) (93.7) (75.2) (60.8) 0 (42.5) 0
Accumulated Other Comprehensive Income 0.2 0.7 0.6 0.4 0.4 (0.0) 1.0 (0.3) (0.2) 0.2 (0.5) (1.0) (0.6) (2.1) (2.7) (2.3) (1.5) 0 0 0 (41.5) 0 (15.5)
Total Stockholders' Equity 270.9 306.1 340.7 379.5 417.3 428.7 422.4 429.9 269.4 242.4 246.7 206.9 229.6 212.6 233.2 256.0 277.4 298.7 (72.6) (59.0) 40.2 (41.5) 16.3
Total Liabilities & Equity 335.5 377.4 412.9 448.8 486.5 526.3 554.6 582.0 510.8 469.2 485.0 494.0 475.6 252.1 274.5 295.9 316.7 305.8 132.4 143.5 0 43.5 0
Debt Metrics
Total Debt 49.8 50.9 52.4 54.7 57.0 59.2 61.3 64.4 66.4 68.2 69.1 73.0 16.2 25.9 28.0 29.9 31.9 0 0 0 0 0 0
Net Debt (26.7) (39.5) (40.9) (17.7) (10.8) (42.0) (16.7) (120.8) (2.0) 0.6 17.2 (6.7) (211.4) (19.2) (25.4) (61.0) (52.8) (291.1) (122.2) (136.9) (39.0) (39.0) (16.8)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (39.7) (39.2) (44.1) (43.1) (17.3) 1.1 (14.0) 55.0 23.5 (9.5) 35.5 (25.9) (6.7) (24.6) (25.1) (23.2) (21.7) (18.4) (14.4) (9.9) (8.4) (8.7) (7.0) (5.4) (5.4)
Depreciation & Amortization 0.8 (2.8) 1.2 1.0 0.9 1.0 0.9 0.9 0.9 0.7 0.8 0.7 0.5 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.2 0.1 0.1 0.1 0.1
Stock-Based Compensation 0 4.4 0 5.0 5.1 4.7 4.9 4.6 3.7 3.8 0 0 2.8 2.9 0 2.5 1.8 1.5 0.6 0.3 0.2 0.1 0.1 0.1 0.1
Change in Working Capital (7.0) 2.4 10.2 8.5 (25.9) (35.9) (12.8) (18.5) (51.6) 3.0 (62.3) (11.3) 207.0 (6.0) (5.5) 2.0 (1.6) (3.8) (0.7) 1.4 (0.3) 1.8 1.2 (1.5) (1.5)
Other Non-Cash Items 4.2 3.0 4.4 (1.0) (1.3) (2.5) (3.2) (2.3) (2.0) (2.0) 1.6 1.5 (0.2) (0.1) 2.7 0.1 0.1 (0.1) 0.2 0 0 0.0 0 0.2 0.2
Operating Cash Flow (41.7) (32.2) (28.3) (29.5) (38.5) (31.6) (24.3) 39.8 (25.5) (4.0) (24.5) (35.1) 203.4 (27.3) (27.5) (18.0) (21.0) (20.5) (14.1) (7.9) (8.3) (6.6) (5.6) (6.7) (6.7)
Investing Activities
Capital Expenditure (0.0) 0.2 0.2 (0.3) (1.1) (0.6) (0.6) (1.0) (0.8) (1.0) (1.4) (1.5) (1.7) (0.7) (0.8) (0.8) (0.6) (1.3) (0.8) (1.5) (0.9) (1.5) (0.2) (0.3) (0.3)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 38.8 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (11.8) (18.5) (26.6) (16.6) (80.0) (64.5) (165.6) (110.7) (96.9) (88.5) (76.8) (140.1) (101.8) 0 (39.3) 0 (182.7) 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 38.9 47.4 75.5 50.6 85.9 118.5 83.3 87.4 123.9 108.5 74.5 28.4 63 19.5 30 25 1.7 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 (38.8) 0 0 0 0 0 0 0 0 0 0 0.0 0.0
Investing Cash Flow 27.0 29.1 49.1 33.8 4.8 53.4 (82.9) (24.4) 26.1 19.0 (3.7) (113.3) (40.4) 18.8 (10.1) 24.2 (181.5) (1.3) (0.8) (1.5) (0.9) (1.5) (0.2) (0.3) (0.3)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0.3 1.4 0.4 1.4 0 0 0 0 0.1 0 0 0.0 0.1 190.8 0.1 0.6 0.1 0.1 0 12.5 12.5
Financing Cash Flow 0.1 0.2 0.0 0.3 0.3 1.4 (0.0) 101.4 0.2 0.7 0.4 0.4 19.5 0.4 0.1 0.0 0.1 190.8 0.1 0.2 116.4 0.1 24.9 12.5 12.5
Cash Position
Net Change in Cash (14.6) (2.9) 20.8 4.6 (33.4) 23.2 (107.2) 116.8 0.8 15.7 (27.9) (147.9) 182.5 (8.2) (37.6) 6.2 (202.5) 168.9 (14.8) (9.2) 107.1 (7.9) 19.0 5.6 5.6
Cash at Beginning 91.1 97.2 72.5 71.8 105.2 82.0 189.2 72.4 67.6 51.9 79.7 227.6 49.1 53.3 90.9 88.6 291.1 122.2 136.9 146.2 39.0 47.0 28.0 22.4 0
Cash at End 76.4 94.3 93.3 76.4 71.8 105.2 82.0 189.2 68.4 67.6 51.9 79.7 231.6 45.2 53.3 94.8 88.6 291.1 122.2 136.9 146.2 39.0 47.0 28.0 5.6
Free Cash Flow (41.7) (32.0) (28.1) (29.8) (39.7) (32.2) (24.9) 38.8 (26.4) (5.0) (25.9) (36.6) 201.7 (28.0) (28.3) (18.8) (21.6) (21.9) (14.9) (9.5) (9.2) (8.1) (5.9) (7.0) (7.0)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0.9 1.3 1.6 1.9 20.6 37.4 19.6 94.7 59.1 41.8 43.7 18.2 25.3 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0.1 0.4 (36.7) 1.9 20.6 37.4 19.6 94.7 59.1 41.8 21.5 (8.1) 2.2 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (42.3) (42.2) (47.1) (46.8) (21.8) (5.9) (21.7) 53.4 21.1 4.9 14.0 (16.3) (5.8) (25.6) (25.9) (23.6) (22.2) (18.5) (14.4) (9.9) (8.4) (8.7) (7.0) (5.5) (5.5)
Net Income (39.7) (39.2) (44.1) (43.1) (17.3) 1.1 (14.0) 55.0 23.5 (9.5) 35.5 (25.9) (6.7) (24.6) (25.1) (23.2) (21.7) (18.4) (14.4) (9.9) (8.4) (8.7) (7.0) (5.4) (5.4)
EPS (Diluted) -0.95 -0.95 -1.06 -1.04 -0.42 0.03 -0.35 1.55 0.68 -0.29 1.02 -0.78 -0.21 -0.71 -0.75 -0.72 -0.66 -0.89 -0.51 -0.48 -0.41 -0.42 -0.34 -5.18 -5.18
Balance Sheet
Cash & Equivalents 76.4 90.4 93.3 72.5 67.8 101.2 78.0 185.3 68.4 67.6 51.9 79.7 227.6 45.2 53.3 90.9 84.6 291.1 122.2 136.9 39.0 39.0 16.8
Total Assets 335.5 377.4 412.9 448.8 486.5 526.3 554.6 582.0 510.8 469.2 485.0 494.0 475.6 252.1 274.5 295.9 316.7 305.8 132.4 143.5 0 43.5 0
Total Debt 49.8 50.9 52.4 54.7 57.0 59.2 61.3 64.4 66.4 68.2 69.1 73.0 16.2 25.9 28.0 29.9 31.9 0 0 0 0 0 0
Stockholders' Equity 270.9 306.1 340.7 379.5 417.3 428.7 422.4 429.9 269.4 242.4 246.7 206.9 229.6 212.6 233.2 256.0 277.4 298.7 (72.6) (59.0) 40.2 (41.5) 16.3
Cash Flow
Operating Cash Flow (41.7) (32.2) (28.3) (29.5) (38.5) (31.6) (24.3) 39.8 (25.5) (4.0) (24.5) (35.1) 203.4 (27.3) (27.5) (18.0) (21.0) (20.5) (14.1) (7.9) (8.3) (6.6) (5.6) (6.7) (6.7)
Capital Expenditure (0.0) 0.2 0.2 (0.3) (1.1) (0.6) (0.6) (1.0) (0.8) (1.0) (1.4) (1.5) (1.7) (0.7) (0.8) (0.8) (0.6) (1.3) (0.8) (1.5) (0.9) (1.5) (0.2) (0.3) (0.3)
Free Cash Flow (41.7) (32.0) (28.1) (29.8) (39.7) (32.2) (24.9) 38.8 (26.4) (5.0) (25.9) (36.6) 201.7 (28.0) (28.3) (18.8) (21.6) (21.9) (14.9) (9.5) (9.2) (8.1) (5.9) (7.0) (7.0)